Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Ourense (32)

2023

  1. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

    Respiratory Research, Vol. 24, Núm. 1

  2. A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients

    Medicina Intensiva, Vol. 47, Núm. 1, pp. 23-33

  3. Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 4, pp. 238-242

  4. Clinical presentation and outcomes of acute heart failure in the critically ill patient: A prospective, observational, multicentre study

    Medicina Intensiva, Vol. 47, Núm. 4, pp. 221-231

  5. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

  6. Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis

    The European respiratory journal, Vol. 61, Núm. 3

  7. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  8. Management of patients with suspected or confirmed antibiotic allergy. Executive summary of guidance from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 3, pp. 181-186

  9. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

    Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945

  10. Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study

    The Journal of infection, Vol. 86, Núm. 3, pp. 256-308

  11. Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review

    Journal of Clinical Medicine, Vol. 12, Núm. 20

2022

  1. Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults

    Antibiotics, Vol. 11, Núm. 9

  2. Enhancing sepsis management through machine learning techniques: A review

    Medicina Intensiva, Vol. 46, Núm. 3, pp. 140-156

  3. Impact of one year of pandemic on Spanish Intensive Care Units

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 392-400

  4. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

  5. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study

    The Lancet Regional Health - Europe, Vol. 18

  6. Resuscitation strategy for patients with sepsis and septic shock

    Medicina Intensiva, Vol. 46, pp. 60-71

2021

  1. Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors

    Intensive and Critical Care Nursing

  2. Reply to “Critically ill patients infected with HIV: 15 years of experience”

    Medicina Intensiva

2020

  1. Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients in the coronavirus disease (COVID-19)

    Medicina Intensiva, Vol. 44, Núm. 6, pp. 371-388